Mydecine Provides Q4 2023 Business Update

VANCOUVER, British Columbia, Oct. 26, 2023 -- Mydecine Innovations Group Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

Related Keywords

United States ,United Kingdom ,Canada ,Vancouver ,British Columbia ,America ,Canadian ,British ,Josh Bartch ,Joshua Bartch ,Steve Cohen ,University Of Alberta ,Mydecine Innovations Group Inc ,Health Canada ,Biotechnology Business Development Centre ,Johns Hopkins University ,Canadian Critical Drug Initiative ,Mydecine Innovations Group ,Innovations Group ,Applied Pharmaceutical Innovation ,Canadian Government ,Mindset Pharma ,North America ,Johns Hopkins ,Chief Executive ,Markets ,